Dr. Ahmed Al jebawi, MD (he/him) is an Endocrinologist in Anderson, IN with over 17 years of experience. What is your opinion of Dr. Ahmed Al jebawi, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ahmed Al jebawi, MD has received over $26,954 which includes payments from the following companies:
$14,787.45 from AstraZeneca Pharmaceuticals LP
$3,261.27 from Janssen Pharmaceuticals, Inc
$1,343.29 from sanofi-aventis U.S. LLC
$1,318.53 from Novo Nordisk Inc
$997.39 from LILLY USA, LLC
$922.04 from Tandem Diabetes Care, Inc.
$725.83 from Corcept Therapeutics
$394.85 from Merck Sharp & Dohme Corporation
$356.54 from Amgen Inc.
$291.70 from INSULET CORPORATION
$270.07 from MannKind Corporation
$234.71 from Valeritas, Inc.
$206.09 from Shire North American Group Inc
$184.32 from Medtronic MiniMed, Inc.
$184.00 from GlaxoSmithKline, LLC.
$150.51 from Radius Health, Inc.
$141.63 from Abbott Laboratories
$136.84 from Endo Pharmaceuticals Inc.
$126.84 from Takeda Pharmaceuticals America, Inc.
$108.05 from Boehringer Ingelheim Pharmaceuticals, Inc.
Payments received by Dr. Ahmed Al jebawi, MD were from the following categories:
$13,530.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!